Investment Highlights
Home » Investors » Financial Highlights » Investment Highlights
Positive changes; Excellent outlook
- 2007 Pro Forma revenues of ~$150 million
- Last four quarters growth rate of >30 percent
- Outpacing market growth – market share gains
- Merger cost synergies identified ~$6.8 million
- Strength in worldwide tissue sourcing
- Outlook for continued revenue, earnings and cash flow increases
- Expected revenue growth ~25 percent for FY:08